194 related articles for article (PubMed ID: 29337370)
1. Modulating Gene Expression in Epstein-Barr Virus (EBV)-Positive B Cell Lines with CRISPRa and CRISPRi.
Wang LW; Trudeau SJ; Wang C; Gerdt C; Jiang S; Zhao B; Gewurz BE
Curr Protoc Mol Biol; 2018 Jan; 121():31.13.1-31.13.18. PubMed ID: 29337370
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9-Mediated Genome Editing in Epstein-Barr Virus-Transformed Lymphoblastoid B-Cell Lines.
Jiang S; Wang LW; Walsh MJ; Trudeau SJ; Gerdt C; Zhao B; Gewurz BE
Curr Protoc Mol Biol; 2018 Jan; 121():31.12.1-31.12.23. PubMed ID: 29337376
[TBL] [Abstract][Full Text] [Related]
3. RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes.
Wang C; Li D; Zhang L; Jiang S; Liang J; Narita Y; Hou I; Zhong Q; Zheng Z; Xiao H; Gewurz BE; Teng M; Zhao B
J Virol; 2019 Jul; 93(13):. PubMed ID: 31019051
[TBL] [Abstract][Full Text] [Related]
4. Targeted Modulation of Chicken Genes In Vitro Using CRISPRa and CRISPRi Toolkit.
Chapman B; Han JH; Lee HJ; Ruud I; Kim TH
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107664
[TBL] [Abstract][Full Text] [Related]
5. CRISPR Screening in Single Cells.
Henriksson J
Methods Mol Biol; 2019; 1979():395-406. PubMed ID: 31028650
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Epstein-Barr virus DNA load in latently infected nasopharyngeal carcinoma cells by CRISPR/Cas9.
Yuen KS; Wang ZM; Wong NM; Zhang ZQ; Cheng TF; Lui WY; Chan CP; Jin DY
Virus Res; 2018 Jan; 244():296-303. PubMed ID: 28456574
[TBL] [Abstract][Full Text] [Related]
7. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements.
Thakore PI; D'Ippolito AM; Song L; Safi A; Shivakumar NK; Kabadi AM; Reddy TE; Crawford GE; Gersbach CA
Nat Methods; 2015 Dec; 12(12):1143-9. PubMed ID: 26501517
[TBL] [Abstract][Full Text] [Related]
8. Mutagenesis and Genome Engineering of Epstein-Barr Virus in Cultured Human Cells by CRISPR/Cas9.
Yuen KS; Chan CP; Kok KH; Jin DY
Methods Mol Biol; 2017; 1498():23-31. PubMed ID: 27709566
[TBL] [Abstract][Full Text] [Related]
9. CRISPR interference and its applications.
Ghavami S; Pandi A
Prog Mol Biol Transl Sci; 2021; 180():123-140. PubMed ID: 33934834
[TBL] [Abstract][Full Text] [Related]
10. A multiplexed gRNA piggyBac transposon system facilitates efficient induction of CRISPRi and CRISPRa in human pluripotent stem cells.
Hazelbaker DZ; Beccard A; Angelini G; Mazzucato P; Messana A; Lam D; Eggan K; Barrett LE
Sci Rep; 2020 Jan; 10(1):635. PubMed ID: 31959800
[TBL] [Abstract][Full Text] [Related]
11. The Epstein-Barr Virus Enhancer Interaction Landscapes in Virus-Associated Cancer Cell Lines.
Ding W; Wang C; Narita Y; Wang H; Leong MML; Huang A; Liao Y; Liu X; Okuno Y; Kimura H; Gewurz B; Teng M; Jin S; Sato Y; Zhao B
J Virol; 2022 Sep; 96(18):e0073922. PubMed ID: 36094314
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300.
Wang C; Zhou H; Xue Y; Liang J; Narita Y; Gerdt C; Zheng AY; Jiang R; Trudeau S; Peng CW; Gewurz BE; Zhao B
J Virol; 2018 May; 92(9):. PubMed ID: 29467311
[TBL] [Abstract][Full Text] [Related]
13. Gene Editing in B-Lymphoma Cell Lines Using CRISPR/Cas9 Technology.
Bai B; Myklebust JH; Wälchli S
Methods Mol Biol; 2020; 2115():445-454. PubMed ID: 32006416
[TBL] [Abstract][Full Text] [Related]
14. A CRISPR Interference Platform for Efficient Genetic Repression in
Wensing L; Sharma J; Uthayakumar D; Proteau Y; Chavez A; Shapiro RS
mSphere; 2019 Feb; 4(1):. PubMed ID: 30760609
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional Knockdown in Pneumococci Using CRISPR Interference.
Kjos M
Methods Mol Biol; 2019; 1968():89-98. PubMed ID: 30929208
[TBL] [Abstract][Full Text] [Related]
16. An efficient KRAB domain for CRISPRi applications in human cells.
Alerasool N; Segal D; Lee H; Taipale M
Nat Methods; 2020 Nov; 17(11):1093-1096. PubMed ID: 33020655
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells.
Yuen KS; Chan CP; Wong NM; Ho CH; Ho TH; Lei T; Deng W; Tsao SW; Chen H; Kok KH; Jin DY
J Gen Virol; 2015 Mar; 96(Pt 3):626-636. PubMed ID: 25502645
[TBL] [Abstract][Full Text] [Related]
18. Practical Considerations for Using Pooled Lentiviral CRISPR Libraries.
McDade JR; Waxmonsky NC; Swanson LE; Fan M
Curr Protoc Mol Biol; 2016 Jul; 115():31.5.1-31.5.13. PubMed ID: 27366891
[TBL] [Abstract][Full Text] [Related]
19. Protocols for CRISPR-Cas9 Screening in Lymphoma Cell Lines.
Webster DE; Roulland S; Phelan JD
Methods Mol Biol; 2019; 1956():337-350. PubMed ID: 30779043
[TBL] [Abstract][Full Text] [Related]
20. Effective Blocking of Microbial Transcriptional Initiation by dCas9-NG-Mediated CRISPR Interference.
Kim B; Kim HJ; Lee SJ
J Microbiol Biotechnol; 2020 Dec; 30(12):1919-1926. PubMed ID: 32958732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
